Network News
Third funding phase for collaboration between research and industry – BMBF funds five-year project with ten million euros The goal of the interdisciplinary research campus “Mannheim Molecular Intervention Environment” (M²OLIE) is to provide tailored treatment for cancer patients with oligometastases that is both minimally invasive and efficient. Based at the Mannheim University Hospital, 25 research […]
read more
AGC Biologics Honored for Excellence in Contract Development and Manufacturing
Today, we announced that our company won two awards from the annual CDMO Leadership Awards, sponsored by Outsourced Pharma and Life Science Connect. AGC Biologics was named a winner in both the “Biologics – Global” and “Cell & Gene – Global” categories and is one of the few in the industry that scored high enough […]
read more
Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing.
Basel, Switzerland, 12 March 2025 – Celonic Group, a Swiss-Based Quality contract development and manufacturing organization (CDMO), has announced that it is integrating Merck’s Breez™ micro-bioreactor platform into its process development. This addition will further enhance Celonic’s capabilities in monoclonal antibody (mAb) development and manufacturing by enabling highly efficient, scalable perfusion-based bioprocessing from early-stage development to […]
read more
Dieter Schwarz Foundation provides long-term funding for application-oriented basic research and innovative talent pool
Together with the Max Planck Society, the foundation promotes pioneering research and talent in Heilbronn The Max Planck Society and the Dieter Schwarz Foundation (DSS) have embarked on a groundbreaking initiative. On March 13, 2025, they signed an agreement through which the foundation will support an innovative approach by the Max Planck Institute for Medical […]
read more
HEIDELBERG UNIVERSITY HOSPITAL AMONG THE WORLD’S BEST HOSPITALS IN 2025
The US magazine “Newsweek” has once again named Heidelberg University Hospital (UKHD) one of the best hospitals in the world. In the “World’s Best Hospitals 2025” ranking, which is compiled by “Newsweek” in collaboration with the statistics and data platform “Statista”, the UKHD ranks 14th out of 2,400 hospitals worldwide. In Germany, the UKHD is […]
read more
Early Excellence in Science Award for Ivana Winkler
The Bayer Foundation’s Early Excellence in Science Award 2024 in the category of Data Science goes to Ivana Winkler of the German Cancer Research Center (DKFZ). Winkler’s work uncovered the unexpected effect of female reproductive capacity: the constantly recurring remodeling of the organs of the female reproductive tract during the sexual cycle leads to fibrosis […]
read more
Frank Winkler receives the Brain Prize 2025
This year, the most highly endowed award in the neurosciences and neuromedical research honors pioneering work on the interactions between the nervous system and brain tumors: Neurologist Frank Winkler, who conducts research at the University of Heidelberg and at the German Cancer Research Center (DKFZ) and treats patients with brain tumors at Heidelberg University Hospital, […]
read more
Zukunft braucht Menschen: Podiumsdiskussion zu Fachkräften im Gesundheitswesen
Nicht nur in der Versorgung, sondern auch in der Wirtschaft fehlen Fachkräfte in der Gesundheitsindustrie. Bei einer Podiumsdiskussion am 11. März 2025, die am Vortag der Jobmesse T5 in Stuttgart stattfindet, will das Forum Gesundheitsstandort Baden-Württemberg zu den Themen Fachkräfte gewinnen, Wirtschaft stärken und Gesundheit fördern diskutieren. Ob Medizintechnik, Pharma oder Biotechnologie – Baden-Württemberg ist […]
read more
Heart drug Beyonttra™ (acoramidis) approved in EU for treatment of transthyretin amyloidosis in adults with cardiomyopathy
Approval based on positive results from Phase III ATTRibute-CM study / Beyonttra™ is a near-complete (≥90%) stabilizer of transthyretin (TTR) minimizing amyloid formation / Phase III ATTRibute-CM study with Beyonttra™ has shown clear benefits on cardiovascular endpoints already starting as early as 3 months after treatment initiation Berlin, February 11, 2025 – The European Commission has […]
read more
